This site uses tracking information. Visit our privacy policy. Click to agree to this policy and not see this again.

Ophthalmology and Visual Sciences

Fuchs Endothelial Dystrophy:

35-year-old female with blurry vision OU lasting hours in the morning

Fuchs Endothelial Dystrophy:

35-year-old female with blurry vision OU lasting hours in the morning
Andrew Doan, MD, PhD, Andrew Lee, MD
February 21, 2005

Chief Complaint: 35-year-old female with complaint of intermittent blurry vision OU lasting hours.

History of Present Illness: Patient was sent to neuro-ophthalmology for evaluation of blurry vision OU. The patient complained of decreased vision upon awakening that is not associated with pain. She stated that it's difficult for her to read. The patient also mentioned that her vision seems to clear up as the day progresses.

EXAM:

  • Vision: 20/25 OU at distance and near.
  • Pupils: 5 mm in dark, 2 mm in light, no RAPD.
  • Extraocular Motility: Full motility without pain.
  • IOP: 18 mmHg OU.
  • Visual Field: Full OU.
  • DFE: normal macula, vessels, and periphery OU.
  • SLE: notable for a beaten metal appearance of the corneal endothelium OU
Corneal Guttae
Slit beam through cornea. Notice the imperfections (guttae) of the corneal endothelium on the left side of the beam.
Specular Microscopy
Specular microscopy showed low endothelial cell count. Less than 1800 cells/mm2. Most people have more than 2000-3000 cells/mm2 (average of 2400 cells/mm2)

Discussion

The diagnosis is Fuchs endothelial dystrophy due to endothelial cell loss. Patients have worse vision in the morning because of the eyes being closed during the night causing a buildup of corneal edema (because the endothelium helps keep the cornea dry and clear). During the day, with the eyes open, the cornea becomes a little more dehydrated. Patients can be treated with dehydrating ointments (5% NaCl) or even with a hair dryer in the earlier symptomatic stages prior to PK.

The dark areas on the specular microscopy are regions where the endothelial cells have died (guttae). Because these cells are terminally differentiated cells, they do not divide, so the remaining cells have to stretch to cover more area.

Diagnosis: Fuchs endothelial dystrophy

EPIDEMIOLOGY

  • Incidence unknown.
  • May have family history.
  • Females:Male ratio is 3:1
  • Age of onset: over age 50.
  • Mild vision problems may develop in younger patients with central cornea guttae.

SIGNS

  • Cornea guttae (beaten metal appearance)
  • Cornea stromal edema
  • Bilateral with possible asymmetry
  • Cornea bullae.
  • Folds in Descemet's membrane.
  • Cornea scarring in the late stages.
  • Low endothelial cell counts on specular microscopy.

SYMPTOMS

  • Glare and blurred vision, typically worse in the morning due to corneal edema from lids being closed at night.
  • Pain with severe corneal decompensation.

TREATMENT

  • Topical NaCl 5% drops 4X/day and ointment at night to help dehydrate the cornea.
  • Reduce IOP with anti-glaucoma medications to reduce cornea edema.
  • Topical steroids may help.
  • Ruptured bullae should be treated as a corneal abrasion.
  • Mild disease may be treated with gentle blow drying of cornea in the morning.
  • Caution with intraocular surgeries that may injure the corneal endothelium, e.g. cataract surgery. BSS(+) [with glutathione] may help reduce loss of endothelial cells during cataract surgery.

Differential Diagnoses

  • Pseudophakic bullous keratopathy
  • Chandler's syndrome (this is a unilateral ICE syndrome with a hammered silver appearance of the corneal endothelium)
  • Posterior polymorphous dystrophy
  • Congenital hereditary endothelial dystrophy (present at birth)
Reference
Suggested citation format:

Doan A, Lee AG: Fuchs Endothelial Dystrophy: 35-year-old female with blurry vision OU lasting hours in the morning. February 21, 2005; Available from: http://www.EyeRounds.org/cases/case5.htm.


last updated: 02-21-2005

Image Permissions:
Creative Commons

Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa are licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.